[SARS-CoV infection and pregnancy].
Identifieur interne : 001B29 ( PubMed/Corpus ); précédent : 001B28; suivant : 001B30[SARS-CoV infection and pregnancy].
Auteurs : Kinga Ksiezakowska ; Magdalena Laszczyk ; Jan Wilczy Ski ; Dorota NowakowskaSource :
- Ginekologia polska [ 0017-0011 ] ; 2008.
English descriptors
- KwdEn :
- Diagnosis, Differential, Female, Fetal Growth Retardation (virology), Humans, Infant, Newborn, Infectious Disease Transmission, Vertical (prevention & control), Pregnancy, Pregnancy Complications, Infectious (diagnosis), Pregnancy Complications, Infectious (therapy), Pregnancy Outcome, Risk Factors, SARS Virus (isolation & purification), Severe Acute Respiratory Syndrome (complications), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (therapy), Severe Acute Respiratory Syndrome (transmission).
- MESH :
- complications : Severe Acute Respiratory Syndrome.
- diagnosis : Pregnancy Complications, Infectious, Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- prevention & control : Infectious Disease Transmission, Vertical.
- therapy : Pregnancy Complications, Infectious, Severe Acute Respiratory Syndrome.
- transmission : Severe Acute Respiratory Syndrome.
- virology : Fetal Growth Retardation.
- Diagnosis, Differential, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Risk Factors.
Abstract
SARS is a highly contagious infection, caused by new coronavirus SARS-CoV. Immunopathological mechanisms responsible for the reaction to SARS-CoV infection have not yet been fully elucidated. Cytokine profile of SARS patients showed marked elevation of Th1 cytokine, interferon gamma, inflammatory cytokines for at least 2 weeks after the onset of the disease. The clinical manifestation of SARS in patients has been of varied nature. Fever of more then 38 degrees C, lasting more then 24 hours, is the most frequently encountered symptom. Other symptoms are non specific and they may include: sore throat, myalgia and nausea. The results of the radiological investigation may appear normal. Infants born to pregnant women with SARS did not appear to have acquired the infection through vertical transmission. However, direct contact with the maternal body fluid which contained SARS-CoV, has put the infants in great danger of perinatal infection. Ribavirin and corticosteroids are usually suggested for the treatment of SARS. However, the ribavirin therapy increases the risk of teratogenic effects in newborns of pregnant women with SARS. Therefore, the usage of this drug is not recommended during pregnancy and lactation.
PubMed: 18510050
Links to Exploration step
pubmed:18510050Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[SARS-CoV infection and pregnancy].</title><author><name sortKey="Ksiezakowska, Kinga" sort="Ksiezakowska, Kinga" uniqKey="Ksiezakowska K" first="Kinga" last="Ksiezakowska">Kinga Ksiezakowska</name><affiliation><nlm:affiliation>Studenckie Koło Naukowe przy Klinice Medycyny Matczyno-Płodowej i Ginekologii (KMMPiG), III Katedry Połoznictwa i Ginekologii (III KPiG), Uniwersytetu Medycznego (UM) w Łodzi.</nlm:affiliation></affiliation></author><author><name sortKey="Laszczyk, Magdalena" sort="Laszczyk, Magdalena" uniqKey="Laszczyk M" first="Magdalena" last="Laszczyk">Magdalena Laszczyk</name></author><author><name sortKey="Wilczy Ski, Jan" sort="Wilczy Ski, Jan" uniqKey="Wilczy Ski J" first="Jan" last="Wilczy Ski">Jan Wilczy Ski</name></author><author><name sortKey="Nowakowska, Dorota" sort="Nowakowska, Dorota" uniqKey="Nowakowska D" first="Dorota" last="Nowakowska">Dorota Nowakowska</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18510050</idno><idno type="pmid">18510050</idno><idno type="wicri:Area/PubMed/Corpus">001B29</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B29</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[SARS-CoV infection and pregnancy].</title><author><name sortKey="Ksiezakowska, Kinga" sort="Ksiezakowska, Kinga" uniqKey="Ksiezakowska K" first="Kinga" last="Ksiezakowska">Kinga Ksiezakowska</name><affiliation><nlm:affiliation>Studenckie Koło Naukowe przy Klinice Medycyny Matczyno-Płodowej i Ginekologii (KMMPiG), III Katedry Połoznictwa i Ginekologii (III KPiG), Uniwersytetu Medycznego (UM) w Łodzi.</nlm:affiliation></affiliation></author><author><name sortKey="Laszczyk, Magdalena" sort="Laszczyk, Magdalena" uniqKey="Laszczyk M" first="Magdalena" last="Laszczyk">Magdalena Laszczyk</name></author><author><name sortKey="Wilczy Ski, Jan" sort="Wilczy Ski, Jan" uniqKey="Wilczy Ski J" first="Jan" last="Wilczy Ski">Jan Wilczy Ski</name></author><author><name sortKey="Nowakowska, Dorota" sort="Nowakowska, Dorota" uniqKey="Nowakowska D" first="Dorota" last="Nowakowska">Dorota Nowakowska</name></author></analytic><series><title level="j">Ginekologia polska</title><idno type="ISSN">0017-0011</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diagnosis, Differential</term><term>Female</term><term>Fetal Growth Retardation (virology)</term><term>Humans</term><term>Infant, Newborn</term><term>Infectious Disease Transmission, Vertical (prevention & control)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (diagnosis)</term><term>Pregnancy Complications, Infectious (therapy)</term><term>Pregnancy Outcome</term><term>Risk Factors</term><term>SARS Virus (isolation & purification)</term><term>Severe Acute Respiratory Syndrome (complications)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (therapy)</term><term>Severe Acute Respiratory Syndrome (transmission)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pregnancy Complications, Infectious</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Vertical</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pregnancy Complications, Infectious</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Fetal Growth Retardation</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Pregnancy</term><term>Pregnancy Outcome</term><term>Risk Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">SARS is a highly contagious infection, caused by new coronavirus SARS-CoV. Immunopathological mechanisms responsible for the reaction to SARS-CoV infection have not yet been fully elucidated. Cytokine profile of SARS patients showed marked elevation of Th1 cytokine, interferon gamma, inflammatory cytokines for at least 2 weeks after the onset of the disease. The clinical manifestation of SARS in patients has been of varied nature. Fever of more then 38 degrees C, lasting more then 24 hours, is the most frequently encountered symptom. Other symptoms are non specific and they may include: sore throat, myalgia and nausea. The results of the radiological investigation may appear normal. Infants born to pregnant women with SARS did not appear to have acquired the infection through vertical transmission. However, direct contact with the maternal body fluid which contained SARS-CoV, has put the infants in great danger of perinatal infection. Ribavirin and corticosteroids are usually suggested for the treatment of SARS. However, the ribavirin therapy increases the risk of teratogenic effects in newborns of pregnant women with SARS. Therefore, the usage of this drug is not recommended during pregnancy and lactation.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18510050</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0017-0011</ISSN><JournalIssue CitedMedium="Print"><Volume>79</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Ginekologia polska</Title><ISOAbbreviation>Ginekol. Pol.</ISOAbbreviation></Journal><ArticleTitle>[SARS-CoV infection and pregnancy].</ArticleTitle><Pagination><MedlinePgn>47-50</MedlinePgn></Pagination><Abstract><AbstractText>SARS is a highly contagious infection, caused by new coronavirus SARS-CoV. Immunopathological mechanisms responsible for the reaction to SARS-CoV infection have not yet been fully elucidated. Cytokine profile of SARS patients showed marked elevation of Th1 cytokine, interferon gamma, inflammatory cytokines for at least 2 weeks after the onset of the disease. The clinical manifestation of SARS in patients has been of varied nature. Fever of more then 38 degrees C, lasting more then 24 hours, is the most frequently encountered symptom. Other symptoms are non specific and they may include: sore throat, myalgia and nausea. The results of the radiological investigation may appear normal. Infants born to pregnant women with SARS did not appear to have acquired the infection through vertical transmission. However, direct contact with the maternal body fluid which contained SARS-CoV, has put the infants in great danger of perinatal infection. Ribavirin and corticosteroids are usually suggested for the treatment of SARS. However, the ribavirin therapy increases the risk of teratogenic effects in newborns of pregnant women with SARS. Therefore, the usage of this drug is not recommended during pregnancy and lactation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ksiezakowska</LastName><ForeName>Kinga</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Studenckie Koło Naukowe przy Klinice Medycyny Matczyno-Płodowej i Ginekologii (KMMPiG), III Katedry Połoznictwa i Ginekologii (III KPiG), Uniwersytetu Medycznego (UM) w Łodzi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laszczyk</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wilczyński</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Nowakowska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials></Author></AuthorList><Language>pol</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Ciaza a zakazenie SARS-CoV.</VernacularTitle></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Ginekol Pol</MedlineTA><NlmUniqueID>0374641</NlmUniqueID><ISSNLinking>0017-0011</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005317" MajorTopicYN="N">Fetal Growth Retardation</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>5</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>6</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>5</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18510050</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001B29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:18510050
|texte= [SARS-CoV infection and pregnancy].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:18510050" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |